This week learn more about CDC's strategies to reduce waterborne diseases; the US change to a trivalent influenza vaccine; new data for Merck's pneumococcal vaccine; and how PCR testing can influence a patient diagnosis and outcome.
Shortened Treatment Regimen Resolves C difficile Infection
C difficile, Antimicrobials, and the Patients Most Affected
Investigational Antibiotic Comparable to Vancomycin in Curing C diff
Enhancing Clostridium difficile Treatment and Prevention Efforts
C diff Update: The Latest in Research, Clinical Management, and Patient Advocacy
Tracking the Evolution of Clostridioides difficile and Implications for Healthcare